litlas
ログインアカウント作成

Daniel J. Hicklin

1990–2023 年に発表

117
論文数
50,512
被引用数
102
h 指数
117
i10 指数

被引用数

Daniel J. Hicklin の年別被引用数1926 年: 被引用 1 件1951 年: 被引用 1 件1984 年: 被引用 4 件1990 年: 被引用 3 件1991 年: 被引用 7 件1992 年: 被引用 8 件1993 年: 被引用 13 件1994 年: 被引用 18 件1995 年: 被引用 7 件1996 年: 被引用 16 件1997 年: 被引用 13 件1998 年: 被引用 20 件1999 年: 被引用 47 件2000 年: 被引用 128 件2001 年: 被引用 216 件2002 年: 被引用 438 件2003 年: 被引用 667 件2004 年: 被引用 727 件2005 年: 被引用 825 件2006 年: 被引用 983 件2007 年: 被引用 914 件2008 年: 被引用 956 件2009 年: 被引用 924 件2010 年: 被引用 883 件2011 年: 被引用 812 件2012 年: 被引用 645 件2013 年: 被引用 598 件2014 年: 被引用 486 件2015 年: 被引用 450 件2016 年: 被引用 438 件2017 年: 被引用 393 件2018 年: 被引用 328 件2019 年: 被引用 967 件2020 年: 被引用 960 件2021 年: 被引用 830 件2022 年: 被引用 555 件2023 年: 被引用 421 件2024 年: 被引用 586 件2025 年: 被引用 225 件2026 年: 被引用 5 件1927〜1950 年は被引用が無いため表示していません1952〜1983 年は被引用が無いため表示していません1985〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,923 件、この内訳の 33.6%中国: 引用元論文 1,607 件、この内訳の 9.1%ドイツ: 引用元論文 1,041 件、この内訳の 5.9%イギリス: 引用元論文 970 件、この内訳の 5.5%イタリア: 引用元論文 903 件、この内訳の 5.1%日本: 引用元論文 725 件、この内訳の 4.1%カナダ: 引用元論文 596 件、この内訳の 3.4%フランス: 引用元論文 589 件、この内訳の 3.3%スイス: 引用元論文 465 件、この内訳の 2.6%スペイン: 引用元論文 408 件、この内訳の 2.3%オーストラリア: 引用元論文 381 件、この内訳の 2.2%オランダ: 引用元論文 381 件、この内訳の 2.2%
0%33.6%その他 20.7%

機関

分野

  • Medicine45.3%
  • Biochemistry, Genetics and Molecular Biology39.5%
  • Immunology and Microbiology8.1%
  • Neuroscience1.9%
  • Materials Science1.5%
  • Engineering1.5%
  • その他2.2%

トピック

  • Angiogenesis and VEGF in Cancer8.7%
  • Cancer, Hypoxia, and Metabolism4.2%
  • Cancer Cells and Metastasis2.9%
  • PI3K/AKT/mTOR signaling in cancer2.2%
  • Immunotherapy and Immune Responses2%
  • Immune cells in cancer2%
  • その他78%

共著者

全論文

検索で開く
  1. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    著者: Rosandra N. Kaplan, Rebecca D. Riba, Stergios Zacharoulis, Anna H. Bramley, Loı̈c Vincent, Carla Costa, Daniel D. MacDonald, David Jin, Koji Shido, Scott Kerns, Zhenping Zhu, Daniel J. Hicklin, Yan Wu, Jeffrey L. Port, Nasser K. Altorki, Elisa Port, Davide Ruggero, Sergey V. Shmelkov, Kristian K. Jensen, Shahin Rafii, David Lyden - Nature 2005 被引用: 3,260

  2. Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

    著者: Daniel J. Hicklin, Lee M. Ellis - Journal of Clinical Oncology 2004 被引用: 3,008

  3. Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    著者: Christine H. Chung, Beloo Mirakhur, Emily Chan, Quynh‐Thu Le, Jordan Berlin, Michael A. Morse, Barbara A. Murphy, Shama M. Satinover, Jacob D. Hosen, David Mauro, Robbert J.C. Slebos, Qinwei Zhou, Diane R. Gold, Tina Hatley, Daniel J. Hicklin, Thomas A.E. Platts‐Mills - New England Journal of Medicine 2008 被引用: 1,483

  4. Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

    著者: Erick J. Morris, Sharda Jha, Clifford R. Restaino, Priya Dayananth, Hugh Zhu, Alan Cooper, Donna Carr, Yongi Deng, Weihong Jin, Stuart Black, Brian J. Long, Jenny Liu, Edward DiNunzio, William T. Windsor, Rumin Zhang, Shuxia Zhao, Minilik Angagaw, Elaine M. Pinheiro, Jagdish Desai, Li Xiao, Gerald W. Shipps, Alan Hruza, James Wang, Joe Kelly, Sunil Paliwal, Xiaolei Gao, Boga Sobhana Babu, Liang Zhu, Pierre Daublain, Ling Zhang, Bart Lutterbach, Marc R. Pelletier, Ulrike Philippar, Phieng Siliphaivanh, David Witter, Paul T. Kirschmeier, W. Robert Bishop, Daniel J. Hicklin, D. Gary Gilliland, Lata Jayaraman, Leigh Zawel, Stephen E. Fawell, Ahmed A. Samatar - Cancer Discovery 2013 被引用: 685

  5. mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

    著者: Kathryn O’Reilly, F. Rojo, Qing‐Bai She, David B. Solit, Gordon B. Mills, Debra L. Smith, Heidi A. Lane, Francesco Hofmann, Daniel J. Hicklin, Dale L. Ludwig, José Baselga, Neal Rosen - Cancer Research 2006 被引用: 2,552

  6. VEGF-targeted therapy: mechanisms of anti-tumour activity

    著者: Lee M. Ellis, Daniel J. Hicklin - Nature reviews. Cancer 2008 被引用: 1,668

  7. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

    著者: Ricky T. Tong, Yves Boucher, Sergey V. Kozin, Frank Winkler, Daniel J. Hicklin, Rakesh K. Jain - Cancer Research 2004 被引用: 1,186

  8. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

    著者: Oriol Casanovas, Daniel J. Hicklin, Gabriele Bergers, Douglas Hanahan - Cancer Cell 2005 被引用: 1,609

  9. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    著者: Peter Carmeliet, Lieve Moons, Aernout Luttun, Valeria Vincenti, Veerle Compernolle, Maria De Mol, Yan Wu, Françoise Bono, Laetitia Devy, Heike Beck, Dimitri Scholz, Till Acker, Tina Di Palma, Mieke Dewerchin, Agnès Noël, Ingeborg Stalmans, Adriano Barra, S. Blacher, Thierry VandenDriessche, Annica Pontén, Ulf Eriksson, Karl H. Plate, Jean‐Michel Foidart, Wolfgang Schäper, D. Stephen Charnock‐Jones, Daniel J. Hicklin, Jean‐Marc Herbert, D Collen, M. Graziella Persico - Nature Medicine 2001 被引用: 1,667

  10. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation

    著者: Frank Winkler, Sergey V. Kozin, Ricky T. Tong, Sung‐Suk Chae, Michael F. Booth, Igor Garkavtsev, Lei Xu, Daniel J. Hicklin, Dai Fukumura, Emmanuelle di Tomaso, Lance L. Munn, Rakesh K. Jain - Cancer Cell 2004 被引用: 1,176

  11. Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression

    著者: Christopher J. Nirschl, Heather R. Brodkin, Daniel J. Hicklin, Nesreen Ismail, Kristin Morris, Cynthia Seidel-Dugan, Philipp Steiner, Zoe Steuert, Jenna M. Sullivan, Ethika Tyagi, William M. Winston, Andres Salmeron - Cancer Immunology Research 2022 被引用: 57

  12. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationRole of oxygenation, angiopoietin-1, and matrix metalloproteinases

    著者: F.K. Winkler, Sergey V. Kozin, R. Tong, Su-Kyoung Chae, Megan Booth, Igor Garkavtsev, Li Xu, Daniel J. Hicklin, Dai Fukumura, Emmanuelle DiTomaso - Cancer Cell 2004 被引用: 679

  13. Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance

    著者: Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin, S Ferrone - Advances in immunology 1999 被引用: 1,167

  14. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors

    著者: Mario Peichev, Afzal J. Naiyer, Daniel Peixoto Pereira, Zhenping Zhu, William J. Lane, Mathew Williams, Mehmet Oz, Daniel J. Hicklin, Larry Witte, Malcolm A.S. Moore, Shahin Rafii - Blood 2000 被引用: 2,261

  15. Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

    著者: Lee M. Ellis, Daniel J. Hicklin - Clinical Cancer Research 2009 被引用: 250

  16. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

    著者: Giannoula Klement, Sylvain Baruchel, Janusz Rak, Shan Man, Katherine Clark, Daniel J. Hicklin, Peter Böhlen, Robert S. Kerbel - Journal of Clinical Investigation 2000 被引用: 1,175

  17. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    著者: Bert Oosthuyse, Lieve Moons, Erik Storkebaum, Heike Beck, Dieter Nuyens, Koen Brusselmans, Jo Van Dorpe, Peter W. Hellings, M. Gorselink, Stéphane Heymans, Gregor Theilmeier, Mieke Dewerchin, Vincent Laudenbach, P. Vermylen, Harold Raat, Till Acker, V. Vleminckx, Ludo Van Den Bosch, Neil R. Cashman, Hajime Fujisawa, Maarten R. Drost, Raf Sciot, Frans Bruyninckx, Daniel J. Hicklin, Can İnce, Pierre Gressèns, Florea Lupu, Karl H. Plate, Wim Robberecht, Jean‐Marc Herbert, Désiré Collen, Peter Carmeliet - Nature Genetics 2001 被引用: 1,010

  18. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

    著者: Monica Autiero, Johannes Waltenberger, Didier Communi, Andrea Kranz, Lieve Moons, Diether Lambrechts, Jens Krøll, Stéphane Plaisance, Maria De Mol, Françoise Bono, Stefanie Kliche, Guido Fellbrich, Kurt Ballmer‐Hofer, Domenico Maglione, Ulrike Mayr-Beyrle, Mieke Dewerchin, Saskia Dombrowski, Danica Stanimirovic, Paul Van Hummelen, Christoph Dehio, Daniel J. Hicklin, Graziella Persico, Jean‐Marc Herbert, David Communi, Masabumi Shibuya, D Collen, Edward M. Conway, Peter Carmeliet - Nature Medicine 2003 被引用: 766

  19. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

    著者: David Lyden, Koichi Hattori, Sérgio Dias, Carla Costa, Pamela Blaikie, Linda Butros, Amy Chadburn, Beate Heissig, Willy Marks, Larry Witte, Yan Wu, Daniel J. Hicklin, Zhenping Zhu, Neil R. Hackett, Ronald G. Crystal, Malcolm A.S. Moore, Katherine A. Hajjar, Katia Manova, Robert Benezra, Shahin Rafii - Nature Medicine 2001 被引用: 1,852

  20. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

    著者: Aernout Luttun, Marc Tjwa, Lieve Moons, Yan Wu, Anne Angelillo‐Scherrer, Fang Liao, Janice A. Nagy, Andrea T. Hooper, Josef Priller, Bert De Klerck, Veerle Compernolle, Evis Daci, Peter Böhlen, Mieke Dewerchin, Jean-Marc Herbert, Roy A. Fava, Patrick Matthys, Geert Carmeliet, D Collen, Harold F. Dvorak, Daniel J. Hicklin, Peter Carmeliet - Nature Medicine 2002 被引用: 1,062

  21. Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth

    著者: Pirjo Laakkonen, Marika Waltari, Tanja Holopainen, Takashi Takahashi, Bronislaw Pytowski, Philipp Steiner, Daniel J. Hicklin, Kris Persaud, James R. Tonra, Larry Witte, Kari Alitalo - Cancer Research 2007 被引用: 241

  22. Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells

    著者: Anthony D. Yang, E. Ramsay Camp, Fan Fan, Lanlan Shen, Michael J. Gray, Wenbiao Liu, Ray Somcio, Todd W. Bauer, Yan Wu, Daniel J. Hicklin, Lee M. Ellis - Cancer Research 2006 被引用: 286

  23. A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens

    著者: Urban Emmenegger, Shan Man, Yuval Shaked, Giulio Francia, John Wong, Daniel J. Hicklin, Robert S. Kerbel - Cancer Research 2004 被引用: 135

  24. Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2 + AC133 + Endothelial Precursor Cells

    著者: Muhammad Gill, Sérgio Dias, Koichi Hattori, Mary Rivera, Daniel J. Hicklin, Larry Witte, Leonard N. Girardi, Roger W. Yurt, Harvey N. Himel, Shahin Rafii - Circulation Research 2001 被引用: 799